|
|||||
|
|
The incidence of arthropathy adverse events in efalizumab-treated patients is low and similar to placebo and does not increase with long-term treatment: pooled analysis of data from Phase III clinical trials of efalizumab |
|
| Authors: | Carlo Pincelli Eric Henninger Florence Casset-Semanaz |
| Affiliation: | (1) Department of Medicine, Institute of Dermatology, University of Modena and Reggio Emilia, Modena, Italy;(2) Serono International S.A. , 15bis Chemin des Mines, 1202 Geneva, Switzerland |
| Abstract: | |
| Keywords: | Arthropathy Arthritis Efalizumab Psoriasis Psoriatic arthritis |
| 本文献已被 SpringerLink 等数据库收录！ | |